abstract |
The invention relates to modified Factor IX coding sequence, expression cassette, vectors such as viral (e.g., lenti- or adeno-associated viral) vectors, and gene transfer methods and uses.In particular, to target Factor IX nucleic acid to cells, tissues or organs for expression (transcription) of Factor IX. |